(Q50689698)

17 March 2018

title

Anti-VEGF therapy reduces intestinal inflammation in Endoglin heterozygous mice subjected to experimental colitis. (English)

1 reference

17 March 2018

0 references

1 reference

Daniela S Ardelean

1

1 reference

17 March 2018

Melissa Yin

2

1 reference

17 March 2018

Mirjana Jerkic

3

1 reference

17 March 2018

Madonna Peter

4

1 reference

17 March 2018

Bo Ngan

5

1 reference

17 March 2018

Robert S Kerbel

6

1 reference

17 March 2018

F Stuart Foster

7

1 reference

17 March 2018

Michelle Letarte

8

1 reference

17 March 2018

publication date

9 February 2014

1 reference

17 March 2018

published in

Angiogenesis

1 reference

17 March 2018

volume

17

1 reference

17 March 2018

issue

3

1 reference

17 March 2018

page(s)

641-659

1 reference

17 March 2018

Inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Neutralizing anti-vascular endothelial growth factor (VEGF) antibody reduces severity of experimental ulcerative colitis in rats: direct evidence for the pathogenic role of VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Expression of endoglin mRNA and protein in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

A murine model of hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Inducible expression of human endoglin during inflammation and wound healing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in endoglin heterozygous mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Micro-ultrasound for preclinical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Differential angiogenic regulation of experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

The granulocyte-macrophage colony-stimulating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Monocyte chemoattractant protein-1 (MCP-1): an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Amphiregulin promotes intestinal epithelial regeneration: roles of intestinal subepithelial myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Role of transforming growth factor-β in inflammatory bowel disease and colitis-associated colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Divergence and convergence of TGF-beta/BMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Blocking MAdCAM-1 in vivo reduces leukocyte extravasation and reverses chronic inflammation in experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

VEGF₁₆₄ isoform specific regulation of T-cell-dependent experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

The key role of macrophages in the immunopathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

IL-1 is required for tumor invasiveness and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Characterization and regulation of bv8 in human blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9421-X

10.1007/S10456-014-9421-X

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018